 Connection
Kelly Maloney to Cyclophosphamide
This is a "connection" page, showing publications Kelly Maloney has written about Cyclophosphamide.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.346 |
|
|
|
-
Ross S, Eisenman K, Maloney KW. Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report. J Pediatr Hematol Oncol. 2019 08; 41(6):498-500.
Score: 0.177
-
Hijiya N, Thomson B, Isakoff MS, Silverman LB, Steinherz PG, Borowitz MJ, Kadota R, Cooper T, Shen V, Dahl G, Thottassery JV, Jeha S, Maloney K, Paul JA, Barry E, Carroll WL, Gaynon PS. Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Blood. 2011 Dec 01; 118(23):6043-9.
Score: 0.103
-
Dupuis LL, Lu X, Mitchell HR, Sung L, Devidas M, Mattano LA, Carroll WL, Winick N, Hunger SP, Maloney KW, Kadan-Lottick NS. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group. Cancer. 2016 Apr 01; 122(7):1116-25.
Score: 0.035
-
Myers RM, Balsamo L, Lu X, Devidas M, Hunger SP, Carroll WL, Winick NJ, Maloney KW, Kadan-Lottick NS. A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer. 2014 May 01; 120(9):1417-25.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|